US Patent Issued to Olema Pharmaceuticals, Aurigene Oncology on Sept. 30 for "Acylsulfonamide KAT6A inhibitors" (Indian, American Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,428,379, issued on Sept. 30, was assigned to Olema Pharmaceuticals Inc. (San Francisco) and Aurigene Oncology Ltd. (Karnataka, India).

"Acylsulfonamide KAT6A inhibitors" was invented by Brian R. Hearn (Moraga, Calif.), David C. Myles (Berkeley, Calif.), Reena Chawla (San Francisco), David Yeghikyan (Fremont, Calif.), Chandregowda Venkateshappa (Bangalore, India), Susanta Samajdar (Bangalore, India), Kalisankar Bera (Bangalore, India), Suraj Tatyasaheb Gore (Maharashtra, India) and Raymond A. Ng (Pleasant Hill, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure describes acylsulfonamide compounds of Formula (J), and pharmaceuti...